166 related articles for article (PubMed ID: 33420863)
1. Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer.
Wei M; Wang X; Zimmerman DN; Burt LM; Haaland B; Henry NL
Breast Cancer Res Treat; 2021 May; 187(1):287-294. PubMed ID: 33420863
[TBL] [Abstract][Full Text] [Related]
2. Radiation Without Endocrine Therapy in Older Women With Stage I Estrogen-Receptor-Positive Breast Cancer is Not Associated With a Higher Risk of Second Breast Cancer Events.
Gerber NK; Shao H; Chadha M; Deb P; Gold HT
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):40-51. PubMed ID: 33974886
[TBL] [Abstract][Full Text] [Related]
3. Endocrine therapy initiation and overall survival outcomes with omission of radiation therapy in older Medicare patients with early-stage hormone-receptor-positive breast cancer.
Shen C; Li N; Zhou S; Stahl K; Dodge D; Zhao H
Cancer Med; 2023 Mar; 12(6):6935-6944. PubMed ID: 36428284
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.
Albert JM; Pan IW; Shih YC; Jiang J; Buchholz TA; Giordano SH; Smith BD
Cancer; 2012 Oct; 118(19):4642-51. PubMed ID: 22890779
[TBL] [Abstract][Full Text] [Related]
5. Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis.
Goldberg M; Sutradhar R; Paszat L; Whelan TJ; Gu S; Fong C; Rakovitch E
Breast Cancer Res Treat; 2019 Aug; 176(3):657-667. PubMed ID: 31076954
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
Shen X; Anne PR; Keith SW; Wojcieszynski A; Mishra MV; Bar-Ad V; Showalter TN
Am J Clin Oncol; 2014 Jun; 37(3):241-7. PubMed ID: 23241502
[TBL] [Abstract][Full Text] [Related]
7. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery.
Murphy CT; Li T; Wang LS; Obeid EI; Bleicher RJ; Eastwick G; Johnson ME; Hayes SB; Weiss SE; Anderson PR
Clin Breast Cancer; 2015 Oct; 15(5):381-9. PubMed ID: 25861716
[TBL] [Abstract][Full Text] [Related]
9. The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis.
Bateni SB; Perry LM; Zhao X; Arora M; Daly ME; Stewart SL; Bold RJ; Canter RJ; Sauder CAM
Ann Surg Oncol; 2021 May; 28(5):2463-2471. PubMed ID: 33094375
[TBL] [Abstract][Full Text] [Related]
10. De-escalating adjuvant therapies in older patients with lower risk estrogen receptor-positive breast cancer treated with breast-conserving surgery: A systematic review and meta-analysis.
Savard MF; Clemons M; Hutton B; Jemaan Alzahrani M; Caudrelier JM; Vandermeer L; Liu M; Saunders D; Sienkiewicz M; Stober C; Cole K; Shorr R; Arnaout A; Chang L
Cancer Treat Rev; 2021 Sep; 99():102254. PubMed ID: 34242928
[TBL] [Abstract][Full Text] [Related]
11. Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer.
Eaton BR; Jiang R; Torres MA; Kahn ST; Godette K; Lash TL; Ward KC
Cancer; 2016 Oct; 122(19):3059-68. PubMed ID: 27328114
[TBL] [Abstract][Full Text] [Related]
12. Impact of non-adherence to endocrine therapy on recurrence risk in older women with stage I breast cancer after breast-conserving surgery.
Rodin D; Sutradhar R; Jerzak KJ; Hahn E; Nguyen L; Castelo M; Fatiregun O; Fong C; Mata DGMM; Trebinjac S; Paszat L; Rakovitch E
Breast Cancer Res Treat; 2023 Aug; 201(1):77-87. PubMed ID: 37326765
[TBL] [Abstract][Full Text] [Related]
13. Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study.
LeMasters TJ; Madhavan SS; Sambamoorthi U; Vyas AM
J Womens Health (Larchmt); 2017 Jul; 26(7):735-744. PubMed ID: 28170302
[TBL] [Abstract][Full Text] [Related]
14. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J; Mózsa E; Zaka Z; Polgár C; Major T
Magy Onkol; 2005; 49(3):203, 205-8. PubMed ID: 16249814
[TBL] [Abstract][Full Text] [Related]
15. Patient views and correlates of radiotherapy omission in a population-based sample of older women with favorable-prognosis breast cancer.
Shumway DA; Griffith KA; Hawley ST; Wallner LP; Ward KC; Hamilton AS; Morrow M; Katz SJ; Jagsi R
Cancer; 2018 Jul; 124(13):2714-2723. PubMed ID: 29669187
[TBL] [Abstract][Full Text] [Related]
16. Patterns of care for omission of radiation therapy for elderly women with early-stage breast cancer receiving hormonal therapy.
Rhieu BH; Rajagopalan MS; Sukumvanich P; Kelley JL; Ahrendt GM; Heron DE; Beriwal S
Pract Radiat Oncol; 2015; 5(4):e267-73. PubMed ID: 25620165
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer.
de Boer AZ; Bastiaannet E; de Glas NA; Marang-van de Mheen PJ; Dekkers OM; Siesling S; de Munck L; de Ligt KM; Portielje JEA; Liefers GJ
Breast Cancer Res Treat; 2019 Dec; 178(3):637-645. PubMed ID: 31451977
[TBL] [Abstract][Full Text] [Related]
18. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
[TBL] [Abstract][Full Text] [Related]
19. Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer.
Haque W; Verma V; Hsiao KY; Hatch S; Arentz C; Szeja S; Schwartz M; Niravath P; Bonefas E; Miltenburg D; Brian Butler E; Teh BS
Breast J; 2019 Nov; 25(6):1126-1133. PubMed ID: 31273872
[TBL] [Abstract][Full Text] [Related]
20. Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
Herskovic AC; Wu X; Christos PJ; Nagar H
Clin Breast Cancer; 2018 Oct; 18(5):418-431. PubMed ID: 29530585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
